Form 483

Takeda Ireland Limited Form 483, 2022-02-04

FDA issued a Form 483 to Takeda Ireland Limited on 2022-02-04 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Takeda Ireland Limited · Dublin 22, Ireland · Issued February 4, 2022

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

4 Feb 2022
21 CFR 211.166(a)(4)

Testing in same container - closure system

Cited by Yasamin Ameri

4 Feb 2022
21 CFR 211.192

Written record of investigation incomplete

Cited by Yasamin Ameri

4 Feb 2022
21 CFR 211.194(a)

Complete test data included in records

Cited by Yasamin Ameri

4 Feb 2022
21 CFR 211.22(c)

Approve or reject procedures or specs

Cited by Yasamin Ameri

4 Feb 2022
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Yasamin Ameri

Inspected site

TITakeda Ireland LimitedDublin 22, Ireland

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.166(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(3)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere